Sandbox Reserved 820: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Sandbox_Reserved_ESBS}}
{{Sandbox_Reserved_ESBS}}
<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
<Structure load='2vaf' size='500' frame='true' align='right' caption='Crystal Structure of Human Cardiac Calsequestrin, (PDB code [[2vaf]]) ' scene='56/568018/General_structure/4'/>


<StructureSection load='2vaf' size='450' side='right'caption='Crystal Structure of Human Cardiac Calsequestrin, (PDB code [[2vaf]]) ' scene='56/568018/General_structure/4' >
'''Calsequestrin-2''' (or '''CASQ2''') is the soluble Ca<sup>2+</sup> binding protein in the sarcoplasmic reticulum lumen of the cardiac muscle cells. CASQ2 could be either in a monomeric, homodimeric, or homooligomeric chain form depending on its bounds with Ca<sup>2+</sup>. Mutations of CASQ2 are involved in cardiac diseases such as Catecholaminergic Polymorphic Ventricular Tachycardia.
'''Calsequestrin-2''' (or '''CASQ2''') is the soluble Ca<sup>2+</sup> binding protein in the sarcoplasmic reticulum lumen of the cardiac muscle cells. CASQ2 could be either in a monomeric, homodimeric, or homooligomeric chain form depending on its bounds with Ca<sup>2+</sup>. Mutations of CASQ2 are involved in cardiac diseases such as Catecholaminergic Polymorphic Ventricular Tachycardia.